COMMUNIQUÉS West-GlobeNewswire

Transactions under Novozymes’ stock buyback program
22/05/2018
Please read the full announcement in the attached PDF Attachment 2018_35_Stock_Buybackprogram_EN
Shire announces new hypoparathyroidism data at the 2018 European Congress of Endocrinology
22/05/2018
Shire announces new hypoparathyroidism data at the 2018 European Congress of Endocrinology New Burden of Illness survey data shows patients living with chronic hypoparathyroidism report significant symptom burden Shire [...]
OncoDNA announces screening collaboration with Kura Oncology
22/05/2018
- OncoDNA to support patient enrolment for Kura Oncology’s Phase II trial of tipifarnib - Agreement demonstrates OncoDNA’s biopharma partnership strategy GOSSELIES, Belgium, May 22, 2018 (GLOBE NEWSWIRE) -- OncoDNA (“ [...]
Abattis Bioceuticals Announces Release of New Line of Vaporizers
22/05/2018
VANCOUVER, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT ) (OTC:ATTBF) is pleased to announce the addition of three new vaporizers to its product [...]
Axsome Therapeutics to Present at the 2018 BIO International Convention
22/05/2018
NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018
22/05/2018
CARLSBAD, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
Trevena announces presentations at the American Society of Colon and Rectal Surgeons 2018 Annual Scientific Meeting
22/05/2018
New colorectal surgery data presented from the oliceridine ATHENA Phase 3 open label safety study CHESTERBROOK, Pa., May 22, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced two presentations at [...]
Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge
22/05/2018
Revolutionary “smart” drug could prevent hypoglycemia in people with diabetes BOSTON, May 22, 2018 (GLOBE NEWSWIRE) -- Protomer Technologies of Pasadena, CA, will receive $50,000 in cash and up to $150,000 of in-kind [...]
Transactions in relation to share buyback program
22/05/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Terveystalo Plc: Managers' Transactions
22/05/2018
TERVEYSTALO PLC MANAGERS' TRANSACTIONS 22 May 2018 at 13:40 EEST ____________________________________________ Person subject to the notification requirement Name: Rettig Group AB Position: Closely associated person (X) [...]
Avivagen Announces Drawdown from Credit Facility
22/05/2018
OTTAWA, May 22, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTCPink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]
RavenQuest Provides Corporate Update
22/05/2018
VANCOUVER, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) is pleased to announce the appointment of Lisa MacNeil as [...]
Draft resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on June 05th, 2018
22/05/2018
Draft resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on June 05th, 2018 : 1. Report of the Board on results of operations in 2017. Draft resolution: To take notice of the Report [...]
Zealand grants new warrants under employee warrant program
22/05/2018
Company announcement - No. 15/2018 Zealand grants new warrants under employee warrant program Copenhagen, May 22, 2018 - Zealand Pharma ("Zealand") announces the granting of warrants to the Company's Executive [...]
Aileron Therapeutics Announces Publication of ALRN-6924 Nonclinical Data in T-cell Lymphomas by Researchers at Dana-Farber Cancer Institute
22/05/2018
Data published in Nature Communications show MDM2 and MDMX are targetable vulnerabilities within TP53-wild-type T-cell Lymphomas CAMBRIDGE, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN ), [...]
FIT Biotech Oy: Positive results from gene therapy collaboration with Avacta
22/05/2018
FIT Biotech Oy Company release 22.5.2018 at 9.30 EET Positive results from gene therapy collaboration with Avacta FIT Biotech Oy ("FIT Biotech", FITBIO:FN Finland) today announced that the results from a preclinical [...]
Enzymatica AB: Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus
22/05/2018
Press release Lund May 22, 2018 Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus Enzymatica has entered into a distribution agreement with Qualia Pharma for marketing and sales of ColdZyme® Mouth [...]
Nexstim Plc - first NBT® system for depression ordered in the US
22/05/2018
Company announcement, Helsinki, 22 May 2018, at 9:00 AM Nexstim Plc - first NBT® system for depression ordered in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company [...]
Shire plc : Rule 2.9 Announcement
22/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 22 May 2018 Shire [...]

Pages